FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921910774> ?p ?o ?g. }

• W2921910774 endingPage "1414" @default.
• W2921910774 startingPage "1405" @default.
• W2921910774 abstract "Background: There is limited data on the real-life situation and outcomes of patients with metastatic triple-negative breast cancer (mTNBC) in Germany. The aim of this chart review was to describe the current treatment patterns, resource use and outcomes in this patient group. Methods: Retrospective data collection in 30 gyneco-oncological sites (hospitals and office-based) across Germany between January and April 2017. Index date was defined as initiation of treatment with gemcitabine, vinorelbin, capecitabine or eribulin therapy following discontinuation of taxane and/or anthracycline therapy. Results: In the 91 evaluable patients, median time between primary diagnosis and index date was 20.9 months (range 0-187 months). Ten percent of patients had no distant metastases, while 57% had newly diagnosed metastases. Cancer stage at index date was mostly IV (82 patients). A number of 135 different regimens (monotherapy or combination therapy) were used. For first-line chemo treatment, 29 patients received monotherapy and 54 patients combination therapy. Bevacizumab and paclitaxel were also the most frequently used single substances among all therapy lines together and for first-line therapy. While taxanes were at least occasionally administered for second-line therapy, no patient received taxanes for third-line therapy. Chemotherapy modifications in terms of dose reduction or treatment interruption were rare. However, the therapy was terminated in more than two thirds of all cases. Fifty-nine patients were hospitalized at least once. For first-, second- and third-line therapy, median overall survival was 19.1/10.8/14.6 months, and median progression-free survival was 7.7/2.5/5.6 months. Conclusion: In clinical routine, a wide variety of treatment approaches is applied, while outcomes in terms of survival are poor. New treatment options are needed for this challenging tumor type." @default.
• W2921910774 created "2019-03-22" @default.
• W2921910774 creator A5004711304 @default.
• W2921910774 creator A5015562881 @default.
• W2921910774 creator A5036531617 @default.
• W2921910774 creator A5052269870 @default.
• W2921910774 creator A5055679374 @default.
• W2921910774 creator A5082526040 @default.
• W2921910774 creator A5087399641 @default.
• W2921910774 date "2019-04-04" @default.
• W2921910774 modified "2023-10-03" @default.
• W2921910774 title "Treatment patterns, health care resource use and outcomes in metastatic triple-negative breast cancer in Germany: retrospective chart review study (OBTAIN)" @default.
• W2921910774 cites W1561070017 @default.
• W2921910774 cites W1757407923 @default.
• W2921910774 cites W1839791863 @default.
• W2921910774 cites W1995224853 @default.
• W2921910774 cites W2019305724 @default.
• W2921910774 cites W2022075549 @default.
• W2921910774 cites W2038702727 @default.
• W2921910774 cites W2040881893 @default.
• W2921910774 cites W2051989799 @default.
• W2921910774 cites W2095125222 @default.
• W2921910774 cites W2096027508 @default.
• W2921910774 cites W2118605519 @default.
• W2921910774 cites W2125094267 @default.
• W2921910774 cites W2135601011 @default.
• W2921910774 cites W2139517025 @default.
• W2921910774 cites W2153556154 @default.
• W2921910774 cites W2170602872 @default.
• W2921910774 cites W2345415641 @default.
• W2921910774 cites W2523763608 @default.
• W2921910774 cites W2586337333 @default.
• W2921910774 cites W2588327302 @default.
• W2921910774 cites W2604873860 @default.
• W2921910774 cites W2626249377 @default.
• W2921910774 cites W2745924174 @default.
• W2921910774 cites W2770078888 @default.
• W2921910774 cites W2789481433 @default.
• W2921910774 cites W2803099840 @default.
• W2921910774 cites W2897422388 @default.
• W2921910774 cites W2908646334 @default.
• W2921910774 cites W80971072 @default.
• W2921910774 cites W2911699492 @default.
• W2921910774 doi "https://doi.org/10.1080/03007995.2019.1595551" @default.
• W2921910774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30880482" @default.
• W2921910774 hasPublicationYear "2019" @default.
• W2921910774 type Work @default.
• W2921910774 sameAs 2921910774 @default.
• W2921910774 citedByCount "7" @default.
• W2921910774 countsByYear W29219107742020 @default.
• W2921910774 countsByYear W29219107742021 @default.
• W2921910774 countsByYear W29219107742022 @default.
• W2921910774 countsByYear W29219107742023 @default.
• W2921910774 crossrefType "journal-article" @default.
• W2921910774 hasAuthorship W2921910774A5004711304 @default.
• W2921910774 hasAuthorship W2921910774A5015562881 @default.
• W2921910774 hasAuthorship W2921910774A5036531617 @default.
• W2921910774 hasAuthorship W2921910774A5052269870 @default.
• W2921910774 hasAuthorship W2921910774A5055679374 @default.
• W2921910774 hasAuthorship W2921910774A5082526040 @default.
• W2921910774 hasAuthorship W2921910774A5087399641 @default.
• W2921910774 hasConcept C121608353 @default.
• W2921910774 hasConcept C126322002 @default.
• W2921910774 hasConcept C141071460 @default.
• W2921910774 hasConcept C143998085 @default.
• W2921910774 hasConcept C167135981 @default.
• W2921910774 hasConcept C2775930923 @default.
• W2921910774 hasConcept C2776694085 @default.
• W2921910774 hasConcept C2776802502 @default.
• W2921910774 hasConcept C2777511904 @default.
• W2921910774 hasConcept C2777802072 @default.
• W2921910774 hasConcept C2778715236 @default.
• W2921910774 hasConcept C2780258809 @default.
• W2921910774 hasConcept C530470458 @default.
• W2921910774 hasConcept C71924100 @default.
• W2921910774 hasConceptScore W2921910774C121608353 @default.
• W2921910774 hasConceptScore W2921910774C126322002 @default.
• W2921910774 hasConceptScore W2921910774C141071460 @default.
• W2921910774 hasConceptScore W2921910774C143998085 @default.
• W2921910774 hasConceptScore W2921910774C167135981 @default.
• W2921910774 hasConceptScore W2921910774C2775930923 @default.
• W2921910774 hasConceptScore W2921910774C2776694085 @default.
• W2921910774 hasConceptScore W2921910774C2776802502 @default.
• W2921910774 hasConceptScore W2921910774C2777511904 @default.
• W2921910774 hasConceptScore W2921910774C2777802072 @default.
• W2921910774 hasConceptScore W2921910774C2778715236 @default.
• W2921910774 hasConceptScore W2921910774C2780258809 @default.
• W2921910774 hasConceptScore W2921910774C530470458 @default.
• W2921910774 hasConceptScore W2921910774C71924100 @default.
• W2921910774 hasIssue "8" @default.
• W2921910774 hasLocation W29219107741 @default.
• W2921910774 hasLocation W29219107742 @default.
• W2921910774 hasOpenAccess W2921910774 @default.
• W2921910774 hasPrimaryLocation W29219107741 @default.
• W2921910774 hasRelatedWork W2014131622 @default.
• W2921910774 hasRelatedWork W2020150632 @default.
• W2921910774 hasRelatedWork W2021371461 @default.
• W2921910774 hasRelatedWork W2288325587 @default.

• next